CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
CN Stock MarketDetailed Quotes
688065 Cathay Biotech Inc.
- 51.98
- -0.22-0.42%
Market Closed Apr 30 15:00 CST
37.49BMarket Cap71.99P/E (TTM)
52.43High51.40Low28.35KlotVolume52.09Open52.20Pre Close147.12MTurnover0.49%Turnover Ratio76.67P/E (Static)721.29MShares56.9852wk High2.13P/B30.32BFloat Cap32.4852wk Low62.64Limit Up583.38MShs Float140.21Historical High41.76Limit Down1.97%Amplitude32.48Historical Low0.19Dividend TTM51.89Avg Price15.74KlotAsk0.37%Div YieldTTM100Lot Size12.16KlotBid
Cathay Biotech Inc. Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 116.48%10.8B | -0.81%5.35B | -20.32%4.64B | -24.84%4.63B | -18.09%4.99B | -14.37%5.39B | -16.26%5.82B | -21.65%6.17B | -29.47%6.09B | -34.63%6.29B |
| Transactional financial assets | 0.00%469.25K | 0.00%469.25K | 0.00%469.25K | 0.00%469.25K | 0.00%469.25K | 0.00%469.25K | 0.00%469.25K | 0.00%469.25K | 0.00%469.25K | 0.00%469.25K |
| Notes receivable and accounts receivable | 23.80%448.95M | 13.59%347.73M | 16.31%419.08M | 9.77%394.29M | -2.77%362.65M | -30.26%306.12M | -13.28%360.3M | 3.61%359.2M | 2.24%372.96M | 62.14%438.96M |
| -Notes receivable | 70.38%120.89M | 59.88%100.51M | 101.64%105.55M | -3.13%88.81M | 107.22%70.96M | 29.47%62.86M | 3.49%52.35M | 334.74%91.68M | 1,129.65%34.24M | 326.67%48.56M |
| -Accounts receivable | 12.47%328.06M | 1.63%247.22M | 1.81%313.53M | 14.19%305.48M | -13.89%291.69M | -37.69%243.26M | -15.60%307.95M | -17.83%267.52M | -6.44%338.72M | 50.53%390.4M |
| Other receivables (including interest and dividends) | 20.62%10.57M | 1.97%10.56M | -42.18%6.56M | -94.40%7.01M | -59.47%8.76M | -12.17%10.35M | -8.27%11.35M | 1,172.64%125.18M | 382.62%21.62M | 79.28%11.79M |
| -Other receivable | ---- | 1.97%10.56M | ---- | -94.40%7.01M | ---- | -12.17%10.35M | ---- | 1,172.64%125.18M | ---- | 79.28%11.79M |
| Advance payment | 111.80%124.33M | 114.82%65.57M | 41.51%82.56M | 6.56%59.89M | 6.87%58.7M | -39.58%30.52M | -11.52%58.34M | -36.95%56.2M | -40.94%54.93M | -24.33%50.52M |
| Inventories | -15.36%1.16B | -19.49%1.18B | -15.85%1.27B | -10.90%1.33B | -11.72%1.37B | -6.82%1.47B | -3.23%1.51B | 5.99%1.49B | 21.56%1.56B | 32.78%1.57B |
| Receivable financing | -2.33%67.09M | 41.24%112.15M | 95.57%73.01M | 174.74%103.02M | 16.38%68.69M | 222.74%79.4M | -22.88%37.33M | 9.85%37.5M | 92.82%59.02M | 447.15%24.6M |
| Other current assets | 15.78%335.6M | 12.50%323.12M | 34.40%319.73M | 58.01%298.88M | 144.93%289.85M | 254.94%287.22M | 468.65%237.88M | 344.24%189.15M | -54.00%118.34M | -65.11%80.92M |
| Total current assets | 81.05%12.95B | -2.43%7.39B | -15.26%6.81B | -18.97%6.83B | -13.56%7.15B | -10.68%7.57B | -11.64%8.04B | -14.02%8.43B | -22.43%8.27B | -25.62%8.48B |
| Non Current assets | ||||||||||
| Investment real estate | ---- | ---- | ---- | ---- | ---- | ---- | --20.29M | --20.63M | ---- | ---- |
| Fixed assets | ---- | -0.85%3.9B | ---- | 9.33%4.01B | ---- | 12.19%3.93B | ---- | 70.92%3.67B | ---- | 58.60%3.51B |
| Constru in process | ---- | 9.43%5.91B | ---- | 41.60%5.6B | ---- | 74.55%5.4B | ---- | 76.36%3.96B | ---- | 308.06%3.09B |
| Construction materials | ---- | -5.83%42.81M | ---- | 11.72%41.16M | ---- | -36.93%45.46M | ---- | 73.57%36.84M | ---- | 13,766.15%72.07M |
| Intangible assets | -0.84%692.97M | -2.67%685.04M | -1.99%689.21M | -1.94%694.28M | -12.01%698.84M | -9.52%703.85M | -10.06%703.17M | -6.78%708.03M | 3.96%794.23M | 1.23%777.87M |
| Long deferred expense | -11.55%5.73M | 29.05%6.42M | -86.52%7.11M | -87.16%6.92M | -24.84%6.48M | -30.61%4.98M | 720.00%52.71M | 639.95%53.93M | -3.86%8.62M | -25.12%7.17M |
| Deferred tax assets | 30.56%220.61M | 32.41%210.37M | 58.66%177.17M | 79.36%172.82M | 82.62%168.97M | 79.97%158.88M | 66.37%111.67M | 42.22%96.35M | 40.50%92.53M | 69.12%88.28M |
| Other non current assets | -9.98%818.56M | -14.38%750.4M | -33.22%770.88M | -39.84%831.35M | -45.70%909.26M | -50.17%876.48M | -33.40%1.15B | -12.71%1.38B | 102.67%1.67B | 87.43%1.76B |
| Total non current assets | 2.41%11.74B | 3.30%11.63B | 7.06%11.52B | 14.19%11.5B | 15.52%11.47B | 20.43%11.26B | 31.39%10.76B | 46.35%10.07B | 72.44%9.93B | 95.21%9.35B |
| Total assets | 32.61%24.69B | 1.00%19.02B | -2.49%18.33B | -0.92%18.32B | 2.30%18.62B | 5.64%18.83B | 8.74%18.8B | 10.88%18.49B | 10.83%18.2B | 10.15%17.83B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 1.50%640.11M | 67.09%1.25B | 32.65%691.28M | 46.93%698.92M | 47.86%630.63M | 362.16%746.25M | 89.12%521.14M | 85.03%475.68M | -13.41%426.52M | -78.28%161.47M |
| Notes payable and accounts payable | -5.46%1.37B | -14.35%1.44B | 1.54%1.49B | 26.07%1.48B | 30.44%1.45B | 58.67%1.68B | 112.63%1.47B | 208.25%1.17B | 232.60%1.11B | 250.71%1.06B |
| -Notes payable | ---- | ---- | ---- | ---- | --30M | --30M | 88.88%6.97M | -74.62%6.97M | ---- | ---- |
| -Accounts payable | -3.46%1.37B | -12.79%1.44B | 2.02%1.49B | 26.83%1.48B | 27.74%1.42B | 55.84%1.65B | 112.76%1.46B | 230.29%1.16B | 272.45%1.11B | 265.18%1.06B |
| Contract liabilities | 31.04%36.61M | 241.74%35.81M | 44.90%26.55M | -35.04%12.87M | 77.70%27.94M | -41.15%10.48M | -2.51%18.32M | 58.43%19.82M | -21.88%15.72M | 21.63%17.81M |
| Advance receipts | 0.00%1.02M | 0.00%2.52M | --4.03M | --5.54M | --1.02M | --2.52M | ---- | ---- | ---- | ---- |
| Salaries payable | 31.97%8.31M | 70.36%21.59M | 148.55%16.51M | 313.02%11.05M | -37.87%6.3M | 3.38%12.67M | -75.70%6.64M | -91.30%2.68M | -53.83%10.13M | -34.78%12.26M |
| Taxs payable | -28.18%43.85M | -34.55%42.85M | -1.75%34.04M | -34.63%25.1M | 129.01%61.06M | 81.19%65.47M | -36.75%34.64M | -19.06%38.39M | -58.58%26.66M | -27.75%36.13M |
| Other payable (including interest and dividends) | -48.24%62.03M | -16.32%85.94M | -32.17%70.96M | -7.22%188.8M | 16.72%119.84M | -20.34%102.7M | -12.44%104.61M | -34.71%203.48M | 18.64%102.67M | 48.52%128.92M |
| -Dividend payable | 0.00%831.6K | 0.00%831.6K | --831.6K | 6.20%111.28M | --831.6K | --831.6K | ---- | -44.05%104.79M | ---- | ---- |
| -Other payable | ---- | -16.46%85.1M | ---- | -21.46%77.51M | ---- | -20.98%101.87M | ---- | -20.64%98.69M | ---- | 48.52%128.92M |
| Non current liabilities due within one year | -18.11%372.32M | -95.26%37.17M | -95.29%34.75M | -95.29%34.75M | 8,314.94%454.64M | 14,484.03%784.37M | --737.42M | --737.57M | --5.4M | --5.38M |
| Other current liabilities | 30.16%4.73M | 32.30%4.42M | 54.49%3.45M | -29.52%1.67M | 77.70%3.63M | 54.71%3.34M | -8.56%2.23M | 46.03%2.37M | -21.88%2.04M | 25.52%2.16M |
| Total current liabilities | -7.81%2.54B | -14.43%2.92B | -17.99%2.37B | -7.40%2.45B | 62.01%2.75B | 139.42%3.41B | 143.34%2.89B | 154.67%2.65B | 66.30%1.7B | 16.95%1.42B |
| Current liabilities | ||||||||||
| Long term deferred income | -4.93%382.75M | -3.92%389.29M | 0.81%394.73M | 0.82%400.15M | 0.63%402.59M | 0.20%405.18M | -5.05%391.58M | 40.26%396.88M | 39.17%400.07M | 38.00%404.39M |
| Total non current liabilities | 0.59%1.01B | 54.12%1B | 51.98%966.75M | 50.90%977.66M | -27.81%1B | -52.34%650.51M | -44.33%636.12M | -20.33%647.88M | 167.76%1.39B | 365.79%1.36B |
| Total liabilities | -5.58%3.54B | -3.44%3.92B | -5.39%3.34B | 4.05%3.43B | 21.67%3.75B | 45.58%4.06B | 51.40%3.53B | 77.91%3.3B | 100.40%3.09B | 84.61%2.79B |
| Shareholders equity | ||||||||||
| Paid-in capital | 23.64%721.29M | 0.00%583.38M | 0.00%583.38M | 0.02%583.38M | 0.02%583.38M | 0.02%583.38M | 0.02%583.38M | 39.98%583.28M | 39.98%583.28M | 39.98%583.28M |
| Capital reserve funds | 67.67%14.3B | -0.06%8.52B | -0.21%8.53B | -0.23%8.53B | -0.21%8.53B | -0.17%8.53B | 0.15%8.55B | -1.65%8.55B | -1.65%8.55B | -1.70%8.54B |
| Surplus reserve funds | 142.81%238.97M | 142.81%238.97M | 0.39%98.42M | 0.39%98.42M | 0.39%98.42M | 0.39%98.42M | 6.44%98.03M | 6.44%98.03M | 6.44%98.03M | 6.44%98.03M |
| Retained profit | 12.40%2.44B | 11.50%2.31B | 14.23%2.3B | 13.44%2.21B | 16.58%2.17B | 14.46%2.07B | 15.48%2.02B | 21.80%1.94B | 14.05%1.86B | 24.88%1.81B |
| Less:Treasury stock | 8.76%155.13M | 22.93%155.13M | 20.68%145.13M | 52.23%144.12M | 50.66%142.63M | 33.30%126.19M | 27.03%120.26M | 106.52%94.67M | --94.67M | --94.67M |
| Other composite income | 28.66%2.03M | -150.24%-1.83M | 35.64%3.87M | 115.39%859.07K | -63.43%1.58M | -38.47%3.65M | -76.12%2.85M | -182.12%-5.58M | 145.46%4.31M | 296.58%5.94M |
| Specific reserves | 33.79%14.4M | 35.28%14.61M | 43.69%12.58M | 36.92%11.98M | 22.96%10.76M | 23.40%10.8M | 29.90%8.75M | 29.90%8.75M | 12.96%8.75M | 29.90%8.75M |
| Shareholders equity without minority interests | 56.08%17.56B | 3.07%11.51B | 2.24%11.39B | 1.83%11.28B | 2.20%11.25B | 1.97%11.16B | 2.36%11.14B | 2.95%11.08B | 1.55%11.01B | 2.79%10.95B |
| Minority interests | -0.81%3.58B | -0.41%3.59B | -12.75%3.6B | -12.32%3.61B | -12.01%3.61B | -11.75%3.61B | 1.37%4.13B | 1.28%4.11B | 1.59%4.1B | 1.66%4.09B |
| Total shareholder equity | 42.26%21.15B | 2.22%15.1B | -1.82%14.99B | -2.00%14.89B | -1.66%14.86B | -1.76%14.77B | 2.09%15.27B | 2.49%15.19B | 1.56%15.11B | 2.48%15.04B |
| Total liabilityies and equity | 32.61%24.69B | 1.00%19.02B | -2.49%18.33B | -0.92%18.32B | 2.30%18.62B | 5.64%18.83B | 8.74%18.8B | 10.88%18.49B | 10.83%18.2B | 10.15%17.83B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | -- | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.